Interpretation of Chinese guideline on prevention and treatment for chronic hepatitis B (2011version) -status quo and prospect of antiviral therapy

Yang Song; Cheng Jun

Issue 8

Aug. 2011

Turn off MathJax

Article Contents

References

Article Navigation > Journal of Clinical Hepatology > 2011 > 27(8): 794-795+800

PDF( 1100 KB)

Interpretation of Chinese guideline on prevention and treatment for chronic hepatitis B (2011version) -status quo and prospect of antiviral therapy

Published Date: 2011-08-20

Abstract

- hepatitis B,
- chronic

FullText(HTML)

References(10)

References

[1] 中华医学会.慢性乙型肝炎防治指南 (2010年版) [J].中国肝脏病杂志, 2011, 3 (1) :40-56.

[2]Lok AS, McMahon BJ.Chronic hepatitis B:update 2009[J].Hepatology, 2009, 50 (3) :661-662.

[3]Pawlotsky JM.EASL Clinical Practice Guidelines:management ofchronic hepatitis B[J].J Hepatol, 2009, 50 (2) :243-260.

[4]Karabay O, Tamer A, Tahtaci M, et al.Effectiveness of lamivudineand interferon-alpha combination therapy versus interferon-alphamonotherapy for the treatment of HBeAg-negative chronic hepatitis Bpatients:a randomized clinical trial[J].J Microbiol Immunol Infect, 2005, 38 (4) :262-266.

[5]Lampertico P, Vigano M, Manenti E, et al.Low resistance to adefo-vir combined with lamivudine:a 3-year study of 145 lamivudine-resistant hepatitis B patients[J].Gastroenterology, 2007, 133 (5) :1445-1451.

[6]慢性乙型肝炎联合抗病毒治疗专家共识委员会.慢性乙型肝炎联合抗病毒治疗专家共识[J].中华实验和临床感染病杂志 (电子版) , 2011, 5 (2) :224-233.

[7]Keeffe EB, Zeuzem S, Koff RS, et al.Report of an internationalworkshop:roadmap for management of patients receiving oral therapyfor chronic hepatitis B[J].Clin Gastroenterol Hepatol, 2007, 5 (8) :890-897.

[8]慢性丙型肝炎抗病毒治疗专家委员会.慢性丙型肝炎抗病毒治疗专家共识[J].中华实验和临床感染病杂志 (电子版) , 2009, 3 (1) :343-352.

[9]Wursthorn K, Jaroszewicz J, Zacher BJ, et al.Correlation betweenthe Elecsys HBsAg II assay and the Architect assay for the quantifi-cation of hepatitis B surface antigen (HBsAg) in the serum[J].JClin Virol, 2011, 50 (4) :292-296.

[10]Thompson AJ, Nguyen T, Iser D, et al.Serum hepatitis B surface anti-gen and hepatitis B e antigen titers:disease phase influences correlationwith viral load and intrahepatic hepatitis B virus markers[J].Hepatolo-gy, 2010, 51 (6) :1933-1944.

Relative Articles

[1]	Ru JIA, Pingping ZHANG, Yuan YUAN, Yiyang HU, Qin FENG. Differences and application value of plasma bile acids in tumors of the liver[J]. Journal of Clinical Hepatology, 2024, 40(10): 2042-2048. doi: 10.12449/JCH241018
[2]	YANG Xu, SUN WenBing, GAO Jun. Diagnosis and treatment of hepatic vascular tumors[J]. Journal of Clinical Hepatology, 2020, 36(11): 2569-2573. doi: 10.3969/j.issn.1001-5256.2020.11.039
[3]	WANG WenHui, DUAN XuHua, LI Hao, LI FengYao, JU ShuGuang, WANG ManZhou, REN JianZhuang, HAN XinWei. Effect of arsenic trioxide-loaded CalliSpheres beads in the treatment of rabbits with VX2 liver tumor[J]. Journal of Clinical Hepatology, 2020, 36(12): 2730-2734. doi: 10.3969/j.issn.1001-5256.2020.12.018
[4]	ZHANG ZhongLin, YUAN YuFeng. Key operating points of laparoscopic hepatectomy for liver tumor in difficult locations[J]. Journal of Clinical Hepatology, 2020, 36(12): 2663-2666. doi: 10.3969/j.issn.1001-5256.2020.12.006
[5]	Li ShanShan, Zhang Ke, Cheng ShuJie, Yang JiHong, Gao Feng, Li JingHua. Current status and future perspectives of the application of medical 3D visualization technology in accurate surgery of liver tumors[J]. Journal of Clinical Hepatology, 2019, 35(5): 1114-1117. doi: 10.3969/j.issn.1001-5256.2019.05.042
[6]	Wang ZhiYu, Gu SanWei, Chen XiaoQian, Cai YanJun. Clonorchiasis misdiagnosed as hepatic tumor: a case report[J]. Journal of Clinical Hepatology, 2018, 34(3): 602-603. doi: 10.3969/j.issn.1001-5256.2018.03.033
[7]	Chen WeiXia, Wang Lei, Liu Yang, Ji Guang, Xing LianJun. Expression of dendritic cell subsets in patients with different stages of chronic HBV infection:a comparative analysis[J]. Journal of Clinical Hepatology, 2017, 33(3): 458-461. doi: 10.3969/j.issn.1001-5256.2017.03.012
[8]	Lu NingNing, Sun Bin, Cui XiongWei, Long Jiang, Gao WenFeng, Zheng JiaSheng. Diagnosis and treatment of subcapsular hemorrhage after liver tumor ablation[J]. Journal of Clinical Hepatology, 2017, 33(12): 2326-2330. doi: 10.3969/j.issn.1001-5256.2017.12.014
[9]	Gao Rui, Liu ZhongJing, Chen Fei, Gao Lei, Jiang ChuanWu. Multivariate regression analysis of risk factors for HBV-related primary liver cancer[J]. Journal of Clinical Hepatology, 2014, 30(4): 370-372. doi: 10.3969/j.issn.1001-5256.2014.04.021
[10]	Xu XiuHua, Xiang XiaoXing, Long AiHua, Liu Dan, Wang JingSong. Differential distribution of age and HBV serological markers in liver cirrhosis and non-cirrhotic patients with primary liver cancer[J]. Journal of Clinical Hepatology, 2013, 29(3): 214-216.
[11]	Chen MinHua. Standardization of thermal ablation in treatment of liver tumor[J]. Journal of Clinical Hepatology, 2013, 29(8): 561-563. doi: 10.3969/j.issn.1001-5256.2013.08.001
[12]	Jin WenWen, Xin YongNing, Dong QuanJiang, Zhao ShouFeng, Yu XinJuan, Jiang Man, Xu Jing, Xuan ShiYing. The preliminary study on the relationship between hepatitis B virus BCP gene mutations and HBV-related primary hepatocellular carcinoma in Qingdao[J]. Journal of Clinical Hepatology, 2012, 28(2): 130-134.
[13]	Wang JiPing, Leng JiYan, Cui YaQiong, Zhang Li, Wang Yan. The diagnosis and clinical value of multi-slice spiral CT in children with common liver tumor[J]. Journal of Clinical Hepatology, 2011, 27(7): 718-721.
[14]	Chen Hong, Wang Zhi, Wu Jian. Circulating tumor cells of hepatocellular carcinoma and their clinical implications[J]. Journal of Clinical Hepatology, 2011, 27(8): 796-800.
[15]	Gao BaoHua, Wang Wen, Niu ChunYan, Zheng JianYun, Liu Bing, Luo JianMei. The expression of HMGB1 in hepatocellular carcinoma, paracancerous liver tissue and its significance[J]. Journal of Clinical Hepatology, 2011, 27(8): 850-853.
[17]	Yang BiWei, Gan YuHong, Ye ShengLong, Zhang BoHeng, Ren ZhengGang, Xia JingLin, Wang YanHong, Ge NingLing, Chen Yi, Li LiXin, Le Fan, Zhang Lan. Necrosis range and safety of radiofrequency combined with systemic chemotherapy and radiofrequency alone.[J]. Journal of Clinical Hepatology, 2004, 20(6): 364-365.

Supplements(0)

Cited By

Cited by

Periodical cited type(5)

1.	田春辉，刘业海，汪东，吴静，吴开乐. ECMO辅助抢救甲状腺肿瘤压迫颈段气管致窒息1例. 临床耳鼻咽喉头颈外科杂志. 2021(09): 842-844 .
2.	代星，高犇，李江. 改善脂肪肝移植受者预后的研究进展. 临床肝胆病杂志. 2021(12): 2967-2971 . 本站查看
3.	卢岩，陈娟，张婷，欧阳昭连. 全球体外膜肺氧合临床试验注册现状分析. 中国医疗设备. 2020(06): 144-149 .
4.	史志勇，张瑞，樊永强，莱智勇，孙纪三，徐钧. 心脏死亡器官捐献供体评估与保护. 实用器官移植电子杂志. 2020(04): 320-324 .
5.	丘小红，刘少儒，许磊波，刘超. 体外膜肺氧合在供者维护中的应用进展. 器官移植. 2020(06): 658-662 .

Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (3209) PDF downloads(809)